484 filings
Page 5 of 25
6-K
CGEN
Compugen Ltd
8 Sep 20
Current report (foreign)
7:05am
EFFECT
CGEN
Compugen Ltd
10 Aug 20
Notice of effectiveness
12:15am
6-K
CGEN
Compugen Ltd
5 Aug 20
Current report (foreign)
8:55am
CORRESP
CGEN
Compugen Ltd
5 Aug 20
Correspondence with SEC
12:00am
UPLOAD
CGEN
Compugen Ltd
5 Aug 20
Letter from SEC
12:00am
F-3
CGEN
Compugen Ltd
30 Jul 20
Shelf registration (foreign)
7:18am
S-8
CGEN
Compugen Ltd
30 Jul 20
Registration of securities for employees
7:15am
6-K
CGEN
Compugen Ltd
30 Jul 20
Compugen Reports Second Quarter 2020 Results
7:02am
6-K
CGEN
Compugen Ltd
1 Jun 20
Compugen Announces FDA Clearance of IND Application for Phase 1/2
7:05am
6-K
CGEN
Compugen Ltd
27 May 20
Current report (foreign)
7:05am
6-K
CGEN
Compugen Ltd
6 May 20
Compugen Reports First Quarter 2020 Results
7:02am
6-K
CGEN
Compugen Ltd
27 Apr 20
Compugen Presents Data Update from Ongoing Phase 1 Trial of
6:05am
6-K
CGEN
Compugen Ltd
15 Apr 20
Current report (foreign)
7:00am
6-K
CGEN
Compugen Ltd
6 Apr 20
Compugen Announces First Patient Dosed in COM902 Phase 1 Trial for Patients with Advanced Malignancies
7:05am
6-K
CGEN
Compugen Ltd
17 Mar 20
Compugen Announces Closing of $75 Million Public Offering of Ordinary Shares
7:05am
6-K
CGEN
Compugen Ltd
13 Mar 20
Current report (foreign)
4:10pm
424B5
CGEN
Compugen Ltd
12 Mar 20
Prospectus supplement for primary offering
4:38pm
6-K
CGEN
Compugen Ltd
12 Mar 20
Compugen Announces Pricing of $75 Million Public Offering of Ordinary Shares
6:11am
6-K
CGEN
Compugen Ltd
11 Mar 20
Compugen Announces Commencement of Public Offering of Ordinary Shares
4:13pm
424B5
CGEN
Compugen Ltd
11 Mar 20
Prospectus supplement for primary offering
4:10pm